Adam James
Adam James
Director, Caladenia Advisory
Adam has over 15 years’ experience across research and technology commercialisation and complex systems transformation; And is a founder of Emyria (ASX:EMD). He holds a degree in Neuroscience (Pharmacology), an MBA and is WA committee member for Ausbiotech; the representative body for the life sciences sector in Australia. and is a Foundational Fellow of the Collaboration for the Advancement of Sustainable Medical Innovation (CASMI) UCL UK.
He was engaged as a subject matter expert for the development of the Future Health Research and Innovation (FHRI) Fund Report, completed by Deloitte Access Economics for the WA government Future Fund repurposing. He has completed technical due diligence and commercialisation strategy projects for clients spanning large corporate, universities, investors and ASX listed technology companies.
